REFERENCES
1. Press release no 263. International Agency for Research on Cancer. World Health Organization (WHO) 2018. Available from: https://www.who.int/ionizing_radiation/research/iarc/en/. [Last accessed on 23 Nov 2020].
2. Goldstraw P, Chansky K, Crowley J, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol 2016;11:39-51.
3. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Ann Thorac Surg 1995;60:615-22.
4. Bao F, Ye P, Yang Y, et al. Segmentectomy or lobectomy for early stage lung cancer: a meta-analysis. Eur J Cardio-thoracic Surg 2014;46:1-7.
5. Dziedzic R, Zurek W, Marjański T, et al. Stage I non-small-cell lung cancer: long-term results of lobectomy versus sublobar resection from the polish national lung cancer registry. Eur J Cardio-thoracic Surg 2017;52:363-9.
6. Song CY, Sakai T, Kimura D, Tsushima T, Fukuda I. Comparison of perioperative and oncological outcomes between video-assisted segmentectomy and lobectomy for patients with clinical stage IA non-small cell lung cancer: a propensity score matching study. J Thorac Dis 2018;10:4891-901.
7. Cao J, Yuan P, Wang Y, et al. Survival rates after lobectomy, segmentectomy, and wedge resection for non-small cell lung cancer. Ann Thorac Surg 2018;105:1483-91.
8. Moon MH, Moon YK, Moon SW. Segmentectomy versus lobectomy in early non-small cell lung cancer of 2 cm or less in size: a population-based study. Respirology 2018;23:695-703.
9. Ackerson BG, Tong BC, Hong JC, et al. Stereotactic body radiation therapy versus sublobar resection for stage I NSCLC. Lung Cancer 2018;125:185-91.
10. Hiraki T, Gobara H, Mimura H, Matsui Y, Toyooka S, Kanazawa S. Percutaneous radiofrequency ablation of clinical stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 2011;142:24-30.
11. Nagata Y, Hiraoka M, Shibata T, et al. Prospective trial of stereotactic body radiation therapy for both operable and inoperable T1N0M0 non-small cell lung cancer: Japan Clinical Oncology Group Study JCOG0403. Int J Radiat Oncol Biol Phys 2015;93:989-96.
12. Tandberg DJ, Tong BC, Ackerson BG, Kelsey CR. Surgery versus stereotactic body radiation therapy for stage I non-small cell lung cancer: a comprehensive review. Cancer 2018;124:667-78.
13. Nyman J, Hallqvist A, Lund JÅ, et al. SPACE - a randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC. Radiother Oncol 2016;121:1-8.
14. Li C, Wang L, Wu Q, et al. A meta-analysis comparing stereotactic body radiotherapy vs conventional radiotherapy in inoperable stage I non-small cell lung cancer. Medicine (Baltimore) 2020;99:e21715.
15. Falkson CB, Vella ET, Yu E, et al. Radiotherapy with curative intent in patients with early-stage, medically inoperable, non-small-cell lung cancer: a systematic review. Clin Lung Cancer 2017;18:105-21.e5.
16. Varlotto J, Fakiris A, Flickinger J, et al. Matched-pair and propensity score comparisons of outcomes of patients with clinical stage i non-small cell lung cancer treated with resection or stereotactic radiosurgery. Cancer 2013;119:2683-91.
17. Timmerman RD, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for medically inoperable early-stage lung cancer patients. JAMA 2010;303:1070-6.
18. Harris AA, Stang K, Small C, et al. Pretreatment factors influencing radiation pneumonitis after stereotactic body radiation therapy in the treatment of lung cancer. Cureus 2020;12.
19. Morias S, Marcu LG, Short M, et al. Treatment-related adverse effects in lung cancer patients after stereotactic ablative radiation therapy. J Oncol 2018;2018:6483626.
20. Wink KCJ, van Baardwijk A, Troost EGC, De Ruysscher D. Nodal recurrence after stereotactic body radiotherapy for early stage non-small cell lung cancer: incidence and proposed risk factors. Cancer Treat Rev 2017;56:8-15.
21. Altorki NK, Kamel MK, Narula N, et al. Anatomical segmentectomy and wedge resections are associated with comparable outcomes for patients with small cT1N0 non-small cell lung cancer. J Thorac Oncol 2016;11:1984-92.
22. Gossot D, Lutz J, Grigoroiu M, Brian E, Seguin-Givelet A. Thoracoscopic anatomic segmentectomies for lung cancer: technical aspects. J Vis Surg 2016;2:171.
23. Guo Z, Yin W, Pan H, et al. Video-assisted thoracoscopic surgery segmentectomy by non- intubated or intubated anesthesia : a comparative analysis of short-term outcome. J Thorac Dis 2016;8:359-68.
24. Hung MH, Hsu HH, Chan KC, et al. Non-intubated thoracoscopic surgery using internal intercostal nerve block, vagal block and targeted sedation. Eur J Cardiothorac Surg 2014;46:620-5.
25. Charloux A, Quoix E. Lung segmentectomy: does it offer a real functional benefit over lobectomy? Eur Respir Rev 2017;26:170079.
26. Traibi A, Grigoroiu M, Boulitrop C, et al. Predictive factors for complications of anatomical pulmonary segmentectomies. Interact Cardiovasc Thorac Surg 2013;17:838-44.
27. Ettinger DS, Wood DE, Aggarwal C. NCCN clinical practice guidelines in oncology (NCCN Guidelines®) guideline non-small cell lung cancer version 7. 2019. Available from: https://jnccn.org/view/journals/jnccn/17/12/article-p1464.xml?print&print&print. [Last accessed on 3 Dec 2020].
28. Vansteenkiste J, Crino L, Dooms C, et al. 2nd ESMO consensus conference on lung cancer: early stage non-small cell lung cancer consensus on diagnosis, treatment and follow-up. Ann Oncol 2014;25:1462-74.
29. Nakamura K, Saji H, Nakajima R, et al. A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L). Jpn J Clin Oncol 2009;40:271-4.
30. Linden D, Linden K, Oparka J. In patients with resectable non-small-cell lung cancer, is video-assisted thoracoscopic segmentectomy a suitable alternative to thoracotomy and segmentectomy in terms of morbidity and equivalence of resection? Interact Cardiovasc Thorac Surg 2014;19:107-10.
31. Linden D, Linden K, Oparka J. In patients with resectable non-small-cell lung cancer, is video-assisted thoracoscopic segmentectomy a suitable alternative to thoracotomy and segmentectomy in terms of morbidity and equivalence of resection? Interact Cardiovasc Thorac Surg 2014;19:107-10.
32. Ohtaki Y, Shimizu K. Anatomical thoracoscopic segmentectomy for lung cancer. Gen Thorac Cardiovasc Surg 2014;62:586-93.
33. Veronesi G. Robotic lobectomy and segmentectomy for lung cancer: results and operating technique. J Thorac Dis 2015;7:S122-30.
34. Schneider BJ, Daly ME, Kennedy EB, Stiles BM. Stereotactic body radiotherapy for early-stage non?small-cell lung cancer: American society of clinical oncology endorsement of the American society for radiation oncology evidence-based guideline summary. J Oncol Pract 2018;14:180.
35. Tamura M, Matsumoto I, Tanaka Y, et al. Comparison between stereotactic radiotherapy and sublobar resection for non-small cell lung cancer. Ann Thorac Surg 2019;107:1544-50.
36. Yendamuri S, Komaki RR, Correa AM, et al. Comparison of limited surgery and three-dimensional conformal radiation in high-risk patients with stage I non-small cell lung cancer. J Thorac Oncol 2007;2:1022-8.
37. Puri V, Crabtree T, Kymes S, et al. A comparison of surgical intervention and stereotactic body radiation therapy for stage i lung cancer in high-risk patients: a decision analysis. J Thorac Cardiovasc Surg 2012;143:428-36.
38. Grills IS, Mangona V, Welsh R, et al. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer (NSCLC). J Clin Oncol 2010;28:928-35.
39. Forquer J, McGarry R, Kesler K, et al. A matched-pair analysis of sublobar resection and stereotactic body radiotherapy (SBRT) for stage I NSCLC. Int J Radiat Oncol Biol Phys 2007;69:S492-3.
40. Matsuo Y, Chen F, Hamaji M, et al. Comparison of long-term survival outcomes between stereotactic body radiotherapy and sublobar resection for stage i non-small-cell lung cancer in patients at high risk for lobectomy: a propensity score matching analysis. Eur J Cancer 2014;50:2932-8.
41. Fernando HC, Timmerman RD. American College of Surgeons Oncology Group Z4099/Radiation Therapy Oncology Group 1021: a randomized study of sublobar resection compared with stereotactic body radiotherapy for high-risk stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 2012;144:S35-8.
42. Mahmood S, Bilal H, Faivre-Finn C, Shah R. Is stereotactic ablative radiotherapy equivalent to sublobar resection in high-risk surgical patients with Stage I non-small-cell lung cancer? Interact Cardiovasc Thorac Surg 2013;17:845-53.
43. Scanagatta P. Is surgery still worthwhile as compared to stereotactic ablative radiotherapy or CyberKnife in high-risk surgical patients with stage I non-small-celllung cancer? E-comment. Interact Cardiovasc Thorac Surg 2013;17:853.
44. Snee MP, McParland L, Collinson F, et al. The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non. Pilot Feasibility Stud 2016;2:5.
45. Ettinger DS, Wood DE, Aisner DL, et al. Non-Small cell lung - NCCN clinical practice guidelines in oncology, v1. 2021.
46. Onishi H, Shirato H, Nagata Y, et al. Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery? Int J Radiat Oncol Biol Phys 2011;81:1352-8.
47. Deng HY, Wang YC, Ni PZ, et al. Radiotherapy, lobectomy or sublobar resection? A meta-analysis of the choices for treating stage I non-small-cell lung cancer. Eur J Cardio-thoracic Surg 2017;51:203-10.
48. Chen H, Laba JM, Boldt RG, et al. Stereotactic ablative radiation therapy versus surgery in early lung cancer: a meta-analysis of propensity score studies. Int J Radiat Oncol Biol Phys 2018;101:186-94.
49. Iguchi T, Hiraki T, Matsui Y, et al. Survival outcomes of treatment with radiofrequency ablation, stereotactic body radiotherapy, or sublobar resection for patients with clinical stage I non-small-cell lung cancer: a single-center evaluation. J Vasc Interv Radiol 2020;31:1044-51.
50. Bryant AK, Mundt RC, Sandhu AP, et al. Stereotactic body radiation therapy versus surgery for early lung cancer among US veterans. Ann Thorac Surg 2018;105:425-31.
51. Wu J, Bai HX, Chan L, et al. Sublobar resection compared with stereotactic body radiation therapy and ablation for early stage non-small cell lung cancer: a national cancer database study. J Thorac Cardiovasc Surg 2020;160:1350-7.e11.
52. Videtic GM, Donington J, Giuliani M, et al. Stereotactic body radiation therapy for early stage non-small cell lung cancer: executive summary of an ASTRO evidence-based guideline. Pract Radiat Oncol 2017;7:295-301.
53. Gierada D, Pinsky P. Survival after detection of stage I lung cancer by screening in the national lung screening trial. Chest 2020;3:34234-5.
54. Horeweg N, Scholten ET, de Jong PA, et al. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers. Lancet Oncol 2014;15:1342-50.
55. Senan S, Paul MA, Lagerwaard FJ. Treatment of early-stage lung cancer detected by screening: surgery or stereotactic ablative radiotherapy? Lancet Oncol 2013;14:e270-4.
56. Swensen S, Silverstein M, Ilstrup D, et al. The probability of malignancy in solitary pulmonary nodules: application to small radiologically indeterminate nodules. Arch Intern Med 1997;157:849-55.
